nodes	percent_of_prediction	percent_of_DWPC	metapath
Eszopiclone—CYP2C8—Vismodegib—skin cancer	0.143	0.232	CbGbCtD
Eszopiclone—CYP2C9—Vismodegib—skin cancer	0.0995	0.162	CbGbCtD
Eszopiclone—CYP3A4—Imiquimod—skin cancer	0.0835	0.136	CbGbCtD
Eszopiclone—CYP3A4—Temozolomide—skin cancer	0.0835	0.136	CbGbCtD
Eszopiclone—CYP3A4—Vismodegib—skin cancer	0.0579	0.0942	CbGbCtD
Eszopiclone—CYP2C8—Fluorouracil—skin cancer	0.0507	0.0825	CbGbCtD
Eszopiclone—CYP3A4—Vemurafenib—skin cancer	0.0457	0.0744	CbGbCtD
Eszopiclone—CYP2C9—Fluorouracil—skin cancer	0.0353	0.0575	CbGbCtD
Eszopiclone—CYP3A4—Docetaxel—skin cancer	0.0157	0.0255	CbGbCtD
Eszopiclone—TSPO—hindlimb—skin cancer	0.00529	0.108	CbGeAlD
Eszopiclone—TSPO—appendage—skin cancer	0.00454	0.0925	CbGeAlD
Eszopiclone—TSPO—hair follicle—skin cancer	0.00269	0.0549	CbGeAlD
Eszopiclone—GABRA3—neck—skin cancer	0.00262	0.0534	CbGeAlD
Eszopiclone—TSPO—blood vessel—skin cancer	0.00253	0.0515	CbGeAlD
Eszopiclone—TSPO—nipple—skin cancer	0.00183	0.0372	CbGeAlD
Eszopiclone—TSPO—neck—skin cancer	0.00181	0.0368	CbGeAlD
Eszopiclone—GABRG3—head—skin cancer	0.00155	0.0315	CbGeAlD
Eszopiclone—PTGS1—endothelium—skin cancer	0.00152	0.0311	CbGeAlD
Eszopiclone—GABRA4—mammalian vulva—skin cancer	0.00151	0.0307	CbGeAlD
Eszopiclone—PTGS1—blood vessel—skin cancer	0.00141	0.0286	CbGeAlD
Eszopiclone—TSPO—connective tissue—skin cancer	0.00129	0.0264	CbGeAlD
Eszopiclone—TSPO—epithelium—skin cancer	0.00123	0.0251	CbGeAlD
Eszopiclone—GABRA5—head—skin cancer	0.00119	0.0242	CbGeAlD
Eszopiclone—TSPO—skin of body—skin cancer	0.00117	0.0238	CbGeAlD
Eszopiclone—GABRA3—head—skin cancer	0.00111	0.0226	CbGeAlD
Eszopiclone—GABRA4—head—skin cancer	0.00108	0.022	CbGeAlD
Eszopiclone—TSPO—mammalian vulva—skin cancer	0.00107	0.0217	CbGeAlD
Eszopiclone—PTGS1—nipple—skin cancer	0.00102	0.0207	CbGeAlD
Eszopiclone—TSPO—lymphoid tissue—skin cancer	0.000947	0.0193	CbGeAlD
Eszopiclone—TSPO—female reproductive system—skin cancer	0.000913	0.0186	CbGeAlD
Eszopiclone—GABRG2—head—skin cancer	0.000902	0.0184	CbGeAlD
Eszopiclone—GABRB2—head—skin cancer	0.000902	0.0184	CbGeAlD
Eszopiclone—GABRA2—head—skin cancer	0.000824	0.0168	CbGeAlD
Eszopiclone—GABRA1—head—skin cancer	0.000796	0.0162	CbGeAlD
Eszopiclone—TSPO—head—skin cancer	0.000763	0.0155	CbGeAlD
Eszopiclone—PTGS1—connective tissue—skin cancer	0.000721	0.0147	CbGeAlD
Eszopiclone—PTGS1—epithelium—skin cancer	0.000684	0.0139	CbGeAlD
Eszopiclone—PTGS1—skin of body—skin cancer	0.000651	0.0133	CbGeAlD
Eszopiclone—CYP2C8—female reproductive system—skin cancer	0.000627	0.0128	CbGeAlD
Eszopiclone—PTGS1—mammalian vulva—skin cancer	0.000593	0.0121	CbGeAlD
Eszopiclone—Swelling—Docetaxel—skin cancer	0.000585	0.00174	CcSEcCtD
Eszopiclone—Stomatitis—Temozolomide—skin cancer	0.000583	0.00173	CcSEcCtD
Eszopiclone—Urinary tract infection—Temozolomide—skin cancer	0.000582	0.00173	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00058	0.00172	CcSEcCtD
Eszopiclone—GABRA2—lymph node—skin cancer	0.000577	0.0118	CbGeAlD
Eszopiclone—Insomnia—Imiquimod—skin cancer	0.000576	0.00171	CcSEcCtD
Eszopiclone—Paraesthesia—Imiquimod—skin cancer	0.000572	0.0017	CcSEcCtD
Eszopiclone—Chills—Bleomycin—skin cancer	0.000571	0.0017	CcSEcCtD
Eszopiclone—Dyspnoea—Imiquimod—skin cancer	0.000568	0.00169	CcSEcCtD
Eszopiclone—Somnolence—Imiquimod—skin cancer	0.000566	0.00168	CcSEcCtD
Eszopiclone—Photosensitivity reaction—Fluorouracil—skin cancer	0.000564	0.00168	CcSEcCtD
Eszopiclone—Alopecia—Bleomycin—skin cancer	0.000563	0.00167	CcSEcCtD
Eszopiclone—Erythema multiforme—Dactinomycin—skin cancer	0.000562	0.00167	CcSEcCtD
Eszopiclone—Dyspepsia—Imiquimod—skin cancer	0.000561	0.00167	CcSEcCtD
Eszopiclone—CYP2C9—female reproductive system—skin cancer	0.000557	0.0113	CbGeAlD
Eszopiclone—Decreased appetite—Imiquimod—skin cancer	0.000554	0.00165	CcSEcCtD
Eszopiclone—Hypersensitivity—Vemurafenib—skin cancer	0.00055	0.00164	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Imiquimod—skin cancer	0.00055	0.00163	CcSEcCtD
Eszopiclone—Fatigue—Imiquimod—skin cancer	0.000549	0.00163	CcSEcCtD
Eszopiclone—Pain—Imiquimod—skin cancer	0.000545	0.00162	CcSEcCtD
Eszopiclone—Neuropathy peripheral—Fluorouracil—skin cancer	0.00054	0.00161	CcSEcCtD
Eszopiclone—Dermatitis bullous—Docetaxel—skin cancer	0.00054	0.00161	CcSEcCtD
Eszopiclone—Stomatitis—Fluorouracil—skin cancer	0.000537	0.0016	CcSEcCtD
Eszopiclone—Hepatitis—Temozolomide—skin cancer	0.000537	0.0016	CcSEcCtD
Eszopiclone—Conjunctivitis—Fluorouracil—skin cancer	0.000536	0.00159	CcSEcCtD
Eszopiclone—Urinary tract infection—Fluorouracil—skin cancer	0.000536	0.00159	CcSEcCtD
Eszopiclone—Asthenia—Vemurafenib—skin cancer	0.000536	0.00159	CcSEcCtD
Eszopiclone—Hypoaesthesia—Temozolomide—skin cancer	0.000534	0.00159	CcSEcCtD
Eszopiclone—Hallucination—Temozolomide—skin cancer	0.000534	0.00159	CcSEcCtD
Eszopiclone—TSPO—lymph node—skin cancer	0.000534	0.0109	CbGeAlD
Eszopiclone—Pharyngitis—Temozolomide—skin cancer	0.000533	0.00158	CcSEcCtD
Eszopiclone—Chills—Dactinomycin—skin cancer	0.000533	0.00158	CcSEcCtD
Eszopiclone—Oedema peripheral—Temozolomide—skin cancer	0.000529	0.00157	CcSEcCtD
Eszopiclone—Pruritus—Vemurafenib—skin cancer	0.000528	0.00157	CcSEcCtD
Eszopiclone—Alopecia—Dactinomycin—skin cancer	0.000525	0.00156	CcSEcCtD
Eszopiclone—Feeling abnormal—Imiquimod—skin cancer	0.000525	0.00156	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Imiquimod—skin cancer	0.000521	0.00155	CcSEcCtD
Eszopiclone—Epistaxis—Fluorouracil—skin cancer	0.00052	0.00155	CcSEcCtD
Eszopiclone—Ill-defined disorder—Bleomycin—skin cancer	0.000514	0.00153	CcSEcCtD
Eszopiclone—Anaemia—Bleomycin—skin cancer	0.000512	0.00152	CcSEcCtD
Eszopiclone—Diarrhoea—Vemurafenib—skin cancer	0.000511	0.00152	CcSEcCtD
Eszopiclone—Migraine—Docetaxel—skin cancer	0.000508	0.00151	CcSEcCtD
Eszopiclone—PTGS1—female reproductive system—skin cancer	0.000508	0.0104	CbGeAlD
Eszopiclone—Erythema multiforme—Temozolomide—skin cancer	0.000508	0.00151	CcSEcCtD
Eszopiclone—Urticaria—Imiquimod—skin cancer	0.000506	0.0015	CcSEcCtD
Eszopiclone—Abdominal pain—Imiquimod—skin cancer	0.000503	0.0015	CcSEcCtD
Eszopiclone—Body temperature increased—Imiquimod—skin cancer	0.000503	0.0015	CcSEcCtD
Eszopiclone—Tinnitus—Temozolomide—skin cancer	0.000501	0.00149	CcSEcCtD
Eszopiclone—Malaise—Bleomycin—skin cancer	0.0005	0.00149	CcSEcCtD
Eszopiclone—Rhinitis—Fluorouracil—skin cancer	0.000496	0.00147	CcSEcCtD
Eszopiclone—Dizziness—Vemurafenib—skin cancer	0.000494	0.00147	CcSEcCtD
Eszopiclone—Hypoaesthesia—Fluorouracil—skin cancer	0.000492	0.00146	CcSEcCtD
Eszopiclone—Pharyngitis—Fluorouracil—skin cancer	0.000491	0.00146	CcSEcCtD
Eszopiclone—Ataxia—Docetaxel—skin cancer	0.000486	0.00144	CcSEcCtD
Eszopiclone—Chills—Temozolomide—skin cancer	0.000482	0.00143	CcSEcCtD
Eszopiclone—Dehydration—Docetaxel—skin cancer	0.00048	0.00143	CcSEcCtD
Eszopiclone—Ill-defined disorder—Dactinomycin—skin cancer	0.00048	0.00143	CcSEcCtD
Eszopiclone—Anaemia—Dactinomycin—skin cancer	0.000478	0.00142	CcSEcCtD
Eszopiclone—Vomiting—Vemurafenib—skin cancer	0.000475	0.00141	CcSEcCtD
Eszopiclone—Alopecia—Temozolomide—skin cancer	0.000475	0.00141	CcSEcCtD
Eszopiclone—Dry skin—Docetaxel—skin cancer	0.000473	0.00141	CcSEcCtD
Eszopiclone—Myalgia—Bleomycin—skin cancer	0.000472	0.0014	CcSEcCtD
Eszopiclone—Chest pain—Bleomycin—skin cancer	0.000472	0.0014	CcSEcCtD
Eszopiclone—Rash—Vemurafenib—skin cancer	0.000471	0.0014	CcSEcCtD
Eszopiclone—Dermatitis—Vemurafenib—skin cancer	0.00047	0.0014	CcSEcCtD
Eszopiclone—Hypersensitivity—Imiquimod—skin cancer	0.000469	0.00139	CcSEcCtD
Eszopiclone—Headache—Vemurafenib—skin cancer	0.000468	0.00139	CcSEcCtD
Eszopiclone—Discomfort—Bleomycin—skin cancer	0.000466	0.00139	CcSEcCtD
Eszopiclone—Malaise—Dactinomycin—skin cancer	0.000466	0.00139	CcSEcCtD
Eszopiclone—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000465	0.00138	CcSEcCtD
Eszopiclone—Cramp muscle—Docetaxel—skin cancer	0.000465	0.00138	CcSEcCtD
Eszopiclone—Dysgeusia—Temozolomide—skin cancer	0.000458	0.00136	CcSEcCtD
Eszopiclone—Asthenia—Imiquimod—skin cancer	0.000457	0.00136	CcSEcCtD
Eszopiclone—Confusional state—Bleomycin—skin cancer	0.000456	0.00136	CcSEcCtD
Eszopiclone—Anaphylactic shock—Bleomycin—skin cancer	0.000452	0.00134	CcSEcCtD
Eszopiclone—Back pain—Temozolomide—skin cancer	0.000452	0.00134	CcSEcCtD
Eszopiclone—Pruritus—Imiquimod—skin cancer	0.000451	0.00134	CcSEcCtD
Eszopiclone—Infection—Bleomycin—skin cancer	0.000449	0.00134	CcSEcCtD
Eszopiclone—Dysphagia—Docetaxel—skin cancer	0.000446	0.00133	CcSEcCtD
Eszopiclone—Nausea—Vemurafenib—skin cancer	0.000444	0.00132	CcSEcCtD
Eszopiclone—Vision blurred—Temozolomide—skin cancer	0.000441	0.00131	CcSEcCtD
Eszopiclone—Myalgia—Dactinomycin—skin cancer	0.00044	0.00131	CcSEcCtD
Eszopiclone—Tremor—Temozolomide—skin cancer	0.000438	0.0013	CcSEcCtD
Eszopiclone—Alopecia—Fluorouracil—skin cancer	0.000437	0.0013	CcSEcCtD
Eszopiclone—Diarrhoea—Imiquimod—skin cancer	0.000436	0.0013	CcSEcCtD
Eszopiclone—Discomfort—Dactinomycin—skin cancer	0.000435	0.00129	CcSEcCtD
Eszopiclone—Ill-defined disorder—Temozolomide—skin cancer	0.000434	0.00129	CcSEcCtD
Eszopiclone—Anaemia—Temozolomide—skin cancer	0.000432	0.00128	CcSEcCtD
Eszopiclone—Anorexia—Bleomycin—skin cancer	0.000431	0.00128	CcSEcCtD
Eszopiclone—Agitation—Temozolomide—skin cancer	0.00043	0.00128	CcSEcCtD
Eszopiclone—Angioedema—Temozolomide—skin cancer	0.000427	0.00127	CcSEcCtD
Eszopiclone—PTGS1—head—skin cancer	0.000425	0.00865	CbGeAlD
Eszopiclone—CYP3A4—female reproductive system—skin cancer	0.000424	0.00865	CbGeAlD
Eszopiclone—Malaise—Temozolomide—skin cancer	0.000422	0.00125	CcSEcCtD
Eszopiclone—Dizziness—Imiquimod—skin cancer	0.000421	0.00125	CcSEcCtD
Eszopiclone—Vertigo—Temozolomide—skin cancer	0.00042	0.00125	CcSEcCtD
Eszopiclone—Infection—Dactinomycin—skin cancer	0.000419	0.00125	CcSEcCtD
Eszopiclone—Palpitations—Temozolomide—skin cancer	0.000413	0.00123	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000412	0.00123	CcSEcCtD
Eszopiclone—Paraesthesia—Bleomycin—skin cancer	0.000406	0.00121	CcSEcCtD
Eszopiclone—Weight increased—Docetaxel—skin cancer	0.000406	0.00121	CcSEcCtD
Eszopiclone—Vision blurred—Fluorouracil—skin cancer	0.000406	0.00121	CcSEcCtD
Eszopiclone—Convulsion—Temozolomide—skin cancer	0.000405	0.0012	CcSEcCtD
Eszopiclone—Vomiting—Imiquimod—skin cancer	0.000405	0.0012	CcSEcCtD
Eszopiclone—Weight decreased—Docetaxel—skin cancer	0.000404	0.0012	CcSEcCtD
Eszopiclone—Hypertension—Temozolomide—skin cancer	0.000404	0.0012	CcSEcCtD
Eszopiclone—Dyspnoea—Bleomycin—skin cancer	0.000403	0.0012	CcSEcCtD
Eszopiclone—Anorexia—Dactinomycin—skin cancer	0.000402	0.0012	CcSEcCtD
Eszopiclone—Rash—Imiquimod—skin cancer	0.000402	0.00119	CcSEcCtD
Eszopiclone—Dermatitis—Imiquimod—skin cancer	0.000401	0.00119	CcSEcCtD
Eszopiclone—Headache—Imiquimod—skin cancer	0.000399	0.00119	CcSEcCtD
Eszopiclone—Anaemia—Fluorouracil—skin cancer	0.000398	0.00118	CcSEcCtD
Eszopiclone—Myalgia—Temozolomide—skin cancer	0.000398	0.00118	CcSEcCtD
Eszopiclone—Anxiety—Temozolomide—skin cancer	0.000397	0.00118	CcSEcCtD
Eszopiclone—Discomfort—Temozolomide—skin cancer	0.000393	0.00117	CcSEcCtD
Eszopiclone—Decreased appetite—Bleomycin—skin cancer	0.000393	0.00117	CcSEcCtD
Eszopiclone—Neuropathy peripheral—Docetaxel—skin cancer	0.00039	0.00116	CcSEcCtD
Eszopiclone—Dry mouth—Temozolomide—skin cancer	0.000389	0.00116	CcSEcCtD
Eszopiclone—Stomatitis—Docetaxel—skin cancer	0.000388	0.00115	CcSEcCtD
Eszopiclone—Pain—Bleomycin—skin cancer	0.000387	0.00115	CcSEcCtD
Eszopiclone—Conjunctivitis—Docetaxel—skin cancer	0.000387	0.00115	CcSEcCtD
Eszopiclone—Confusional state—Temozolomide—skin cancer	0.000385	0.00114	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000384	0.00114	CcSEcCtD
Eszopiclone—Anaphylactic shock—Temozolomide—skin cancer	0.000382	0.00113	CcSEcCtD
Eszopiclone—Infection—Temozolomide—skin cancer	0.000379	0.00113	CcSEcCtD
Eszopiclone—Nausea—Imiquimod—skin cancer	0.000378	0.00112	CcSEcCtD
Eszopiclone—Epistaxis—Docetaxel—skin cancer	0.000375	0.00112	CcSEcCtD
Eszopiclone—Convulsion—Fluorouracil—skin cancer	0.000373	0.00111	CcSEcCtD
Eszopiclone—Feeling abnormal—Bleomycin—skin cancer	0.000373	0.00111	CcSEcCtD
Eszopiclone—Hyperhidrosis—Temozolomide—skin cancer	0.000369	0.0011	CcSEcCtD
Eszopiclone—Chest pain—Fluorouracil—skin cancer	0.000367	0.00109	CcSEcCtD
Eszopiclone—Myalgia—Fluorouracil—skin cancer	0.000367	0.00109	CcSEcCtD
Eszopiclone—Decreased appetite—Dactinomycin—skin cancer	0.000367	0.00109	CcSEcCtD
Eszopiclone—Fatigue—Dactinomycin—skin cancer	0.000364	0.00108	CcSEcCtD
Eszopiclone—Anorexia—Temozolomide—skin cancer	0.000364	0.00108	CcSEcCtD
Eszopiclone—Discomfort—Fluorouracil—skin cancer	0.000362	0.00108	CcSEcCtD
Eszopiclone—Pain—Dactinomycin—skin cancer	0.000361	0.00107	CcSEcCtD
Eszopiclone—Urticaria—Bleomycin—skin cancer	0.000359	0.00107	CcSEcCtD
Eszopiclone—Rhinitis—Docetaxel—skin cancer	0.000358	0.00106	CcSEcCtD
Eszopiclone—Body temperature increased—Bleomycin—skin cancer	0.000358	0.00106	CcSEcCtD
Eszopiclone—Hepatitis—Docetaxel—skin cancer	0.000357	0.00106	CcSEcCtD
Eszopiclone—Hypoaesthesia—Docetaxel—skin cancer	0.000355	0.00106	CcSEcCtD
Eszopiclone—Confusional state—Fluorouracil—skin cancer	0.000355	0.00105	CcSEcCtD
Eszopiclone—Pharyngitis—Docetaxel—skin cancer	0.000355	0.00105	CcSEcCtD
Eszopiclone—Oedema peripheral—Docetaxel—skin cancer	0.000352	0.00105	CcSEcCtD
Eszopiclone—Anaphylactic shock—Fluorouracil—skin cancer	0.000352	0.00105	CcSEcCtD
Eszopiclone—Infection—Fluorouracil—skin cancer	0.000349	0.00104	CcSEcCtD
Eszopiclone—Feeling abnormal—Dactinomycin—skin cancer	0.000348	0.00103	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000348	0.00103	CcSEcCtD
Eszopiclone—Insomnia—Temozolomide—skin cancer	0.000345	0.00103	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Dactinomycin—skin cancer	0.000345	0.00103	CcSEcCtD
Eszopiclone—Tachycardia—Fluorouracil—skin cancer	0.000343	0.00102	CcSEcCtD
Eszopiclone—Paraesthesia—Temozolomide—skin cancer	0.000343	0.00102	CcSEcCtD
Eszopiclone—Dyspnoea—Temozolomide—skin cancer	0.00034	0.00101	CcSEcCtD
Eszopiclone—Somnolence—Temozolomide—skin cancer	0.000339	0.00101	CcSEcCtD
Eszopiclone—Erythema multiforme—Docetaxel—skin cancer	0.000338	0.001	CcSEcCtD
Eszopiclone—Dyspepsia—Temozolomide—skin cancer	0.000336	0.000999	CcSEcCtD
Eszopiclone—Anorexia—Fluorouracil—skin cancer	0.000335	0.000996	CcSEcCtD
Eszopiclone—Abdominal pain—Dactinomycin—skin cancer	0.000334	0.000991	CcSEcCtD
Eszopiclone—Body temperature increased—Dactinomycin—skin cancer	0.000334	0.000991	CcSEcCtD
Eszopiclone—Hypersensitivity—Bleomycin—skin cancer	0.000333	0.000991	CcSEcCtD
Eszopiclone—Decreased appetite—Temozolomide—skin cancer	0.000332	0.000986	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Temozolomide—skin cancer	0.000329	0.000979	CcSEcCtD
Eszopiclone—Fatigue—Temozolomide—skin cancer	0.000329	0.000978	CcSEcCtD
Eszopiclone—Pain—Temozolomide—skin cancer	0.000326	0.00097	CcSEcCtD
Eszopiclone—Constipation—Temozolomide—skin cancer	0.000326	0.00097	CcSEcCtD
Eszopiclone—Asthenia—Bleomycin—skin cancer	0.000325	0.000965	CcSEcCtD
Eszopiclone—Chills—Docetaxel—skin cancer	0.000321	0.000953	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.00032	0.000952	CcSEcCtD
Eszopiclone—Pruritus—Bleomycin—skin cancer	0.00032	0.000951	CcSEcCtD
Eszopiclone—Insomnia—Fluorouracil—skin cancer	0.000318	0.000945	CcSEcCtD
Eszopiclone—Paraesthesia—Fluorouracil—skin cancer	0.000316	0.000939	CcSEcCtD
Eszopiclone—Alopecia—Docetaxel—skin cancer	0.000316	0.000938	CcSEcCtD
Eszopiclone—Feeling abnormal—Temozolomide—skin cancer	0.000315	0.000935	CcSEcCtD
Eszopiclone—Dyspnoea—Fluorouracil—skin cancer	0.000314	0.000932	CcSEcCtD
Eszopiclone—Somnolence—Fluorouracil—skin cancer	0.000313	0.000929	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Temozolomide—skin cancer	0.000312	0.000928	CcSEcCtD
Eszopiclone—Hypersensitivity—Dactinomycin—skin cancer	0.000311	0.000924	CcSEcCtD
Eszopiclone—Dyspepsia—Fluorouracil—skin cancer	0.00031	0.00092	CcSEcCtD
Eszopiclone—Decreased appetite—Fluorouracil—skin cancer	0.000306	0.000909	CcSEcCtD
Eszopiclone—Dysgeusia—Docetaxel—skin cancer	0.000305	0.000905	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000304	0.000902	CcSEcCtD
Eszopiclone—Urticaria—Temozolomide—skin cancer	0.000303	0.000901	CcSEcCtD
Eszopiclone—Asthenia—Dactinomycin—skin cancer	0.000303	0.0009	CcSEcCtD
Eszopiclone—Body temperature increased—Temozolomide—skin cancer	0.000302	0.000897	CcSEcCtD
Eszopiclone—Abdominal pain—Temozolomide—skin cancer	0.000302	0.000897	CcSEcCtD
Eszopiclone—Back pain—Docetaxel—skin cancer	0.000301	0.000894	CcSEcCtD
Eszopiclone—Pain—Fluorouracil—skin cancer	0.000301	0.000894	CcSEcCtD
Eszopiclone—Muscle spasms—Docetaxel—skin cancer	0.000299	0.000889	CcSEcCtD
Eszopiclone—PTGS1—lymph node—skin cancer	0.000297	0.00606	CbGeAlD
Eszopiclone—Feeling abnormal—Fluorouracil—skin cancer	0.00029	0.000861	CcSEcCtD
Eszopiclone—Diarrhoea—Dactinomycin—skin cancer	0.000289	0.000858	CcSEcCtD
Eszopiclone—Vomiting—Bleomycin—skin cancer	0.000288	0.000855	CcSEcCtD
Eszopiclone—Anaemia—Docetaxel—skin cancer	0.000287	0.000854	CcSEcCtD
Eszopiclone—Rash—Bleomycin—skin cancer	0.000285	0.000848	CcSEcCtD
Eszopiclone—Dermatitis—Bleomycin—skin cancer	0.000285	0.000847	CcSEcCtD
Eszopiclone—Hypersensitivity—Temozolomide—skin cancer	0.000281	0.000836	CcSEcCtD
Eszopiclone—Urticaria—Fluorouracil—skin cancer	0.000279	0.00083	CcSEcCtD
Eszopiclone—Body temperature increased—Fluorouracil—skin cancer	0.000278	0.000826	CcSEcCtD
Eszopiclone—Palpitations—Docetaxel—skin cancer	0.000275	0.000817	CcSEcCtD
Eszopiclone—Asthenia—Temozolomide—skin cancer	0.000274	0.000814	CcSEcCtD
Eszopiclone—Pruritus—Temozolomide—skin cancer	0.00027	0.000803	CcSEcCtD
Eszopiclone—Convulsion—Docetaxel—skin cancer	0.000269	0.000801	CcSEcCtD
Eszopiclone—Nausea—Bleomycin—skin cancer	0.000269	0.000799	CcSEcCtD
Eszopiclone—Hypertension—Docetaxel—skin cancer	0.000268	0.000798	CcSEcCtD
Eszopiclone—Vomiting—Dactinomycin—skin cancer	0.000268	0.000797	CcSEcCtD
Eszopiclone—Rash—Dactinomycin—skin cancer	0.000266	0.000791	CcSEcCtD
Eszopiclone—Chest pain—Docetaxel—skin cancer	0.000265	0.000787	CcSEcCtD
Eszopiclone—Myalgia—Docetaxel—skin cancer	0.000265	0.000787	CcSEcCtD
Eszopiclone—Diarrhoea—Temozolomide—skin cancer	0.000261	0.000776	CcSEcCtD
Eszopiclone—Hypersensitivity—Fluorouracil—skin cancer	0.000259	0.00077	CcSEcCtD
Eszopiclone—Dry mouth—Docetaxel—skin cancer	0.000259	0.00077	CcSEcCtD
Eszopiclone—Confusional state—Docetaxel—skin cancer	0.000256	0.000761	CcSEcCtD
Eszopiclone—Anaphylactic shock—Docetaxel—skin cancer	0.000254	0.000754	CcSEcCtD
Eszopiclone—Dizziness—Temozolomide—skin cancer	0.000252	0.00075	CcSEcCtD
Eszopiclone—Infection—Docetaxel—skin cancer	0.000252	0.000749	CcSEcCtD
Eszopiclone—Nausea—Dactinomycin—skin cancer	0.000251	0.000745	CcSEcCtD
Eszopiclone—Pruritus—Fluorouracil—skin cancer	0.000249	0.000739	CcSEcCtD
Eszopiclone—Tachycardia—Docetaxel—skin cancer	0.000248	0.000736	CcSEcCtD
Eszopiclone—Vomiting—Temozolomide—skin cancer	0.000243	0.000721	CcSEcCtD
Eszopiclone—Anorexia—Docetaxel—skin cancer	0.000242	0.000719	CcSEcCtD
Eszopiclone—Rash—Temozolomide—skin cancer	0.000241	0.000715	CcSEcCtD
Eszopiclone—Diarrhoea—Fluorouracil—skin cancer	0.000241	0.000715	CcSEcCtD
Eszopiclone—Dermatitis—Temozolomide—skin cancer	0.00024	0.000715	CcSEcCtD
Eszopiclone—Headache—Temozolomide—skin cancer	0.000239	0.000711	CcSEcCtD
Eszopiclone—Dizziness—Fluorouracil—skin cancer	0.000233	0.000691	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000231	0.000687	CcSEcCtD
Eszopiclone—Insomnia—Docetaxel—skin cancer	0.00023	0.000682	CcSEcCtD
Eszopiclone—Paraesthesia—Docetaxel—skin cancer	0.000228	0.000677	CcSEcCtD
Eszopiclone—Nausea—Temozolomide—skin cancer	0.000227	0.000674	CcSEcCtD
Eszopiclone—Dyspnoea—Docetaxel—skin cancer	0.000226	0.000673	CcSEcCtD
Eszopiclone—Somnolence—Docetaxel—skin cancer	0.000226	0.000671	CcSEcCtD
Eszopiclone—Vomiting—Fluorouracil—skin cancer	0.000224	0.000665	CcSEcCtD
Eszopiclone—Dyspepsia—Docetaxel—skin cancer	0.000223	0.000664	CcSEcCtD
Eszopiclone—Rash—Fluorouracil—skin cancer	0.000222	0.000659	CcSEcCtD
Eszopiclone—Dermatitis—Fluorouracil—skin cancer	0.000222	0.000658	CcSEcCtD
Eszopiclone—Decreased appetite—Docetaxel—skin cancer	0.000221	0.000656	CcSEcCtD
Eszopiclone—Headache—Fluorouracil—skin cancer	0.00022	0.000655	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Docetaxel—skin cancer	0.000219	0.000651	CcSEcCtD
Eszopiclone—Fatigue—Docetaxel—skin cancer	0.000219	0.00065	CcSEcCtD
Eszopiclone—Pain—Docetaxel—skin cancer	0.000217	0.000645	CcSEcCtD
Eszopiclone—Constipation—Docetaxel—skin cancer	0.000217	0.000645	CcSEcCtD
Eszopiclone—Feeling abnormal—Docetaxel—skin cancer	0.000209	0.000622	CcSEcCtD
Eszopiclone—Nausea—Fluorouracil—skin cancer	0.000209	0.000621	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Docetaxel—skin cancer	0.000208	0.000617	CcSEcCtD
Eszopiclone—Body temperature increased—Docetaxel—skin cancer	0.000201	0.000596	CcSEcCtD
Eszopiclone—Abdominal pain—Docetaxel—skin cancer	0.000201	0.000596	CcSEcCtD
Eszopiclone—Hypersensitivity—Docetaxel—skin cancer	0.000187	0.000556	CcSEcCtD
Eszopiclone—Asthenia—Docetaxel—skin cancer	0.000182	0.000541	CcSEcCtD
Eszopiclone—Pruritus—Docetaxel—skin cancer	0.00018	0.000534	CcSEcCtD
Eszopiclone—Diarrhoea—Docetaxel—skin cancer	0.000174	0.000516	CcSEcCtD
Eszopiclone—Dizziness—Docetaxel—skin cancer	0.000168	0.000499	CcSEcCtD
Eszopiclone—Vomiting—Docetaxel—skin cancer	0.000161	0.00048	CcSEcCtD
Eszopiclone—Rash—Docetaxel—skin cancer	0.00016	0.000476	CcSEcCtD
Eszopiclone—Dermatitis—Docetaxel—skin cancer	0.00016	0.000475	CcSEcCtD
Eszopiclone—Headache—Docetaxel—skin cancer	0.000159	0.000473	CcSEcCtD
Eszopiclone—Nausea—Docetaxel—skin cancer	0.000151	0.000448	CcSEcCtD
